For the purpose of classification for the AJNR, the Oxford Centre for Evidence-Based Medicine Levels of Evidence (2009) is used (also on the AJNR Web site). 6 For neuroradiologists, the questions to be answered primarily involve therapy and diagnosis. Therapy level 1 studies include systematic reviews of randomized controlled trials, and randomized controlled trials with narrow confidence limits. Diagnosis level 1 studies include systematic reviews of level 1 studies, a validating cohort study with good reference standards, or a clinical decision rule tested within 1 clinical center. For reference, a nonconsecutive study is level 3, a case series is level 4, and expert opinion is level 5 (ouch).
Evidence-based medicine defines a hierarchy of clinically relevant information; however, this information is by no means absolute. 7 Certain therapies and treatments may be so effective or dramatic that they will never experience a randomized controlled trial. The oft-cited tongue-in-cheek manuscript evaluating randomized controlled trials in parachute use is a case in point. 8 In our specialty, with its emphasis on technologic advancement, there will be seminal articles that advance the field and which provide important contributions to patient care, but do not achieve level 1-2 status (such as the initial diffusion imaging papers). Despite its flaws and increasing complexity, the sorting and weighting of manuscripts that define high quality and minimal bias is an important foundation upon which evidence-based medicine is built. This journal will do its part to bring such manuscripts to readers.
